The role of 3-O-sulfogalactosylceramide, sulfatide, in the lateral organization of myelin membrane

Neurochemical Research

Volumn 41, Issue 1-2, 2016, Pages 130-143

  Grassi, Sara ^a   Prioni, Simona ^a   Cabitta, Livia ^a   Aureli, Massimo ^a   Sonnino, Sandro ^a   Prinetti, Alessandro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Lipid membrane domains; Lipid rafts; Multiple sclerosis; Sphingolipids; Sulfatide

Indexed keywords

ANTIBODY; CERAMIDE DERIVATIVE; GALACTOLIPID; MYELIN; SULFATIDE;

ARTICLE; CELL MATURATION; LIPID METABOLISM; MYELIN SHEATH; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE;

ANIMALS; ANTIBODIES; HUMANS; MICE; MYELIN SHEATH; SULFOGLYCOSPHINGOLIPIDS;

EID: 84946430959     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1747-2     Document Type: Article

References (113)

1. IUPAC-IUB Joint Commission on Biochemical Nomenclature (1998) Nomenclature of glycolipids. Carbohydr Res 312:167-175
2. Snaidero N, Mobius W, Czopka T, Hekking LH, Mathisen C, Verkleij D, Goebbels S, Edgar J, Merkler D, Lyons DA, Nave KA, Simons M (2014) Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell 156:277-290
3. Chrast R, Saher G, Nave KA, Verheijen MH (2011) Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J Lipid Res 52:419-434
4. O'Brien JS, Sampson EL (1965) Lipid composition of the normal human brain: gray matter, white matter, and myelin. J Lipid Res 6:537-544
5. Jackman N, Ishii A, Bansal R (2009) Oligodendrocyte development and myelin biogenesis: parsing out the roles of glycosphingolipids. Physiology (Bethesda) 24:290-297
6. Taylor CM, Marta CB, Bansal R, Pfeiffer SE (2004) The transport, assembly and function of myelin lipids. Myelin Biol Disord 1:57-88
7. Saher G, Quintes S, Nave KA (2011) Cholesterol: a novel regulatory role in myelin formation. Neuroscientist 17:79-93
8. Stoffel W, Bosio A (1997) Myelin glycolipids and their functions. Curr Opin Neurobiol 7:654-661
9. Eckhardt M (2008) The role and metabolism of sulfatide in the nervous system. Mol Neurobiol 37:93-103
10. Honke K (2013) Biosynthesis and biological function of sulfoglycolipids. Proc Jpn Acad Ser B Phys Biol Sci 89:129-138
11. Sonnino S, Prinetti A (2013) Membrane domains and the ''lipid raft'' concept. Curr Med Chem 20:4-21
12. Sonnino S, Prinetti A (2010) Lipids and membrane lateral organization. Front Physiol 1:153
13. Maggio B (1997) Molecular interactions of the major myelin glycosphingolipids and myelin basic protein in model membranes. Neurochem Res 22:475-481
14. Viani P, Marchesini S, Cervato G, Cestaro B (1986) Calorimetric properties of mixtures of distearoylphosphatidylcholine and sulfatideswith definite fatty acid composition.Biochem Int 12:125-135
15. Boggs JM, Mulholland D, Koshy KM (1990) Mixtures of semisynthetic species of cerebroside sulfate with dipalmitoyl phosphatidylcholine. Thermotropic phase behavior and permeability. Biochem Cell Biol 68:70-82
16. Boggs JM, Koshy KM, Rangaraj G (1993) Thermotropic phase behavior of mixtures of long chain fatty acid species of cerebroside sulfate with different fatty acid chain length species of phospholipid. Biochemistry 32:8908-8922
17. Ruettinger A, Kiselev MA, Hauss T, Dante S, Balagurov AM, Neubert RH (2008) Fatty acid interdigitation in stratum corneum model membranes: a neutron diffraction study. Eur Biophys J 37:759-771
18. Grant CW, Mehlhorn IE, Florio E, Barber KR (1987) A long chain spin label for glycosphingolipid studies: transbilayer fatty acid interdigitation of lactosyl ceramide. Biochim Biophys Acta 902:169-177
19. Boggs JM, Koshy KM (1994) Do the long fatty acid chains of sphingolipids interdigitate across the center of a bilayer of shorter chain symmetric phospholipids? Biochim Biophys Acta 1189:233-241
20. Rintoul DA, Welti R (1989) Thermotropic behavior of mixtures of glycosphingolipids and phosphatidylcholine: effect of monovalent cations on sulfatide and galactosylceramide. Biochemistry 28:26-31
21. Maggio B, Montich GG, Cumar FA (1988) Surface topography of sulfatide and gangliosides in unilamellar vesicles of dipalmitoylphosphatidylcholine. Chem Phys Lipids 46:137-146
22. Wu X, Li QT (1999) Ca2+-induced fusion of sulfatide-containing phosphatidylethanolamine small unilamellar vesicles. J Lipid Res 40:1254-1262
23. Wu X, Li QT (1999) Hydration and stability of sulfatide-containing phosphatidylethanolamine small unilamellar vesicles. Biochim Biophys Acta 1416:285-294
24. Wu X, Lee KH, Li QT (1996) Stability and pH sensitivity of sulfatide-containing phosphatidylethanolamine small unilamellar vesicles. Biochim Biophys Acta 1284:13-19
25. Viani P, Cervato G, Gatti P, Cestaro B (1992) Calcitonin-induced changes in the organization of sulfatide-containing membranes. Biochim Biophys Acta 1106:77-84
26. BjorkqvistYJ,Nybond S,NyholmTK, Slotte JP,Ramstedt B (2008) N-palmitoyl-sulfatide participates in lateral domain formation in complex lipid bilayers. Biochim Biophys Acta 1778:954-962
27. Hao C, Sun R, Zhang J, Chang Y, Niu C (2009) Behavior of sulfatide/cholesterol mixed monolayers at the air/water interface. Colloids Surf B Biointerfaces 69:201-206
28. Stewart RJ, Boggs JM (1990) Dependence of the surface expression of the glycolipid cerebroside sulfate on its lipid environment: comparison of sphingomyelin and phosphatidylcholine. Biochemistry 29:3644-3653
29. Maggio B, Sturtevant JM, Yu RK (1987) Effect of myelin basic protein on the thermotropic behavior of aqueous dispersions of neutral and anionic glycosphingolipids and their mixtures with dipalmitoylphosphatidylcholine. J Biol Chem 262:2652- 2659
30. Simons M, Nave KA (2015) Oligodendrocytes: myelination and axonal support. Cold Spring Harb Perspect Biol. doi:10.1101/ cshperspect.a020479
31. Jessen KR, Mirsky R, Lloyd AC (2015) Schwann cells: development and role in nerve repair. Cold Spring Harb Perspect Biol 7(7):a020487. doi:10.1101/cshperspect.a020487
32. Pernber Z, Molander-Melin M, Berthold CH, Hansson E, Fredman P (2002) Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neurons and astrocytes of adult rat brain. J Neurosci Res 69:86-93
33. Berntson Z, Hansson E, Ronnback L, Fredman P (1998) Intracellular sulfatide expression in a subpopulation of astrocytes in primary cultures. J Neurosci Res 52:559-568
34. Isaac G, Pernber Z, Gieselmann V, Hansson E, Bergquist J, Mansson JE (2006) Sulfatide with short fatty acid dominates in astrocytes and neurons. FEBS J 273:1782-1790
35. Yuki D, Sugiura Y, Zaima N, Akatsu H, Hashizume Y, Yamamoto T, Fujiwara M, Sugiyama K, Setou M (2011) Hydroxylated and non-hydroxylated sulfatide are distinctly distributed in the human cerebral cortex. Neuroscience 193:44-53
36. De Haas CG, Lopes-Cardozo M (1995) Hydroxy- and non-hydroxy- galactolipids in developing rat CNS. Int J Dev Neurosci 13:447-454
37. Pernber Z, Richter K, Mansson JE, Nygren H (2007) Sulfatide with different fatty acids has unique distributions in cerebellum as imaged by time-of-flight secondary ion mass spectrometry (TOF-SIMS). Biochim Biophys Acta 1771:202-209
38. Pfeiffer SE, Warrington AE, Bansal R (1993) The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197
39. Ishizuka I, Inomata M (1979) Sulphated glycoglycerolipids in rat brain: decrease and disappearance after developmental age. J Neurochem 33:387-388
40. Raff MC, Mirsky R, Fields KL, Lisak RP, Dorfman SH, Silberberg DH, Gregson NA, Leibowitz S, Kennedy MC (1978) Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature 274:813-816
41. Hardy R, Reynolds R (1991) Proliferation and differentiation potential of rat forebrain oligodendroglial progenitors both in vitro and in vivo. Development 111:1061-1080
42. Poduslo SE, Miller K (1985) Levels of sulfatide synthesis distinguish oligodendroglia in different stages of maturation. Neurochem Res 10:1285-1297
43. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE (1989) Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 24:548-557
44. Dyer CA, Benjamins JA (1988) Antibody to galactocerebroside alters organization of oligodendroglial membrane sheets in culture. J Neurosci 8:4307-4318
45. Dyer CA, Benjamins JA (1989) Organization of oligodendroglial membrane sheets: II. Galactocerebroside:antibody interactions signal changes in cytoskeleton and myelin basic protein. J Neurosci Res 24:212-221
46. Dyer CA, Benjamins JA (1990) Glycolipids and transmembrane signaling: antibodies to galactocerebroside cause an influx of calcium in oligodendrocytes. J Cell Biol 111:625-633
47. Bansal R, Gard AL, Pfeiffer SE (1988) Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid. J Neurosci Res 21:260-267
48. Bansal R, Pfeiffer SE (1989) Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids. Proc Natl Acad Sci USA 86:6181-6185
49. Bansal R, Winkler S, Bheddah S (1999) Negative regulation of oligodendrocyte differentiation by galactosphingolipids. J Neurosci 19:7913-7924
50. Owens GC, Bunge RP (1990) Schwann cells depleted of galactocerebroside express myelin-associated glycoprotein and initiate but do not continue the process of myelination. Glia 3:118-124
51. Rosenbluth J, Moon D (2003) Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies. J Neurosci Res 71:104-109
52. Svennerholm L, Bostrom K, Jungbjer B (1997) Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes. Acta Neuropathol 94:345-352
53. Crivello NA, Casseus SL, Peterson JW, Smith DE, Booth SL (2010) Age- and brain region-specific effects of dietary vitamin K on myelin sulfatides. J Nutr Biochem 21:1083-1088
54. Braak H, Braak E (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 92:197-201
55. Mitew S, Kirkcaldie MT, Halliday GM, Shepherd CE, Vickers JC, Dickson TC (2010) Focal demyelination in Alzheimer's disease and transgenic mouse models. Acta Neuropathol 119:567-577
56. Marbois BN, Faull KF, Fluharty AL, Raval-Fernandes S, Rome LH (2000) Analysis of sulfatide from rat cerebellum and multiple sclerosis white matter by negative ion electrospray mass spectrometry. Biochim Biophys Acta 1484:59-70
57. Yahara S, Kawamura N, Kishimoto Y, Saida T, Tourtellotte WW (1982) A change in the cerebrosides and sulfatides in a demyelinating nervous system. Development of the methodology and study of multiple sclerosis and Wallerian degeneration. J Neurol Sci 54:303-315
58. Moyano AL, Pituch K, Li G, van Breemen R, Mansson JE, Givogri MI (2013) Levels of plasma sulfatides C18: 0 and C24: 1 correlate with disease status in relapsing-remitting multiple sclerosis. J Neurochem 127:600-604
59. Haghighi S, Lekman A, Nilsson S, Blomqvist M, Andersen O (2012) Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis. Acta Neurol Scand 125:64-70
60. Haghighi S, Lekman A, Nilsson S, Blomqvist M, Andersen O (2013) Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients. J Neurol Sci 326:35-39
61. Halder RC, Jahng A, Maricic I, Kumar V (2007) Mini review: immune response to myelin-derived sulfatide and CNS-demyelination. Neurochem Res 32:257-262
62. Jeon SB, Yoon HJ, Park SH, Kim IH, Park EJ (2008) Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol 181:8077-8087
63. Maricic I, Halder R, Bischof F, Kumar V (2014) Dendritic cells and anergic type I NKT cells play a crucial role in sulfatidemediated immune regulation in experimental autoimmune encephalomyelitis. J Immunol 193:1035-1046
64. Mycko MP, Sliwinska B, Cichalewska M, Cwiklinska H, Raine CS, Selmaj KW (2014) Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination. J Neurosci 34:8646-8658
65. Podbielska M, Hogan EL (2009) Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis? Mult Scler 15:1011-1029
66. Ilyas AA, Chen ZW, Cook SD (2003) Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol 139:76-80
67. Don AS, Hsiao JH, Bleasel JM, Couttas TA, Halliday GM, Kim WS (2014) Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy. Acta Neuropathol Commun 2:150
68. Schulte S, Stoffel W (1993) Ceramide UDPgalactosyltransferase from myelinating rat brain: purification, cloning, and expression. Proc Natl Acad Sci USA 90:10265-10269
69. Stahl N, Jurevics H, Morell P, Suzuki K, Popko B (1994) Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose: ceramide galactosyltransferase. J Neurosci Res 38:234-242
70. Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, Popko B (1996) Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86:209-219
71. Saadat L, Dupree JL, Kilkus J, Han X, Traka M, Proia RL, Dawson G, Popko B (2010) Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice. Glia 58:391-398
72. Meixner M, Jungnickel J, Grothe C, Gieselmann V, Eckhardt M (2011) Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2-hydroxylase. BMC Neurosci 12:22
73. Dupree JL, Coetzee T, Suzuki K, Popko B (1998) Myelin abnormalities in mice deficient in galactocerebroside and sulfatide. J Neurocytol 27:649-659
74. Bosio A, Binczek E, Haupt WF, Stoffel W (1998) Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside- and sulfatide-deficient mice. J Neurochem 70:308-315
75. Dupree JL, Suzuki K, Popko B (1998) Galactolipids in the formation and function of the myelin sheath. Microsc Res Tech 41:431-440
76. Marcus J, Popko B (2002) Galactolipids are molecular determinants of myelin development and axo-glial organization. Biochim Biophys Acta 1573:406-413
77. Dupree JL, Coetzee T, Blight A, Suzuki K, Popko B (1998) Myelin galactolipids are essential for proper node of Ranvier formation in the CNS. J Neurosci 18:1642-1649
78. Dupree JL, Popko B (1999) Genetic dissection of myelin galactolipid function. J Neurocytol 28:271-279
79. Honke K, Hirahara Y, Dupree J, Suzuki K, Popko B, Fukushima K, Fukushima J, Nagasawa T, Yoshida N, Wada Y, Taniguchi N (2002) Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci USA 99:4227-4232
80. Wang C, Wang M, Zhou Y, Dupree JL, Han X (2014) Alterations in mouse brain lipidome after disruption of CST gene: a lipidomics study. Mol Neurobiol 50:88-96
81. Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL (2006) Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53:372-381
82. Ishibashi T, Dupree JL, Ikenaka K, Hirahara Y, Honke K, Peles E, Popko B, Suzuki K, Nishino H, Baba H (2002) A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J Neurosci 22:6507-6514
83. Hoshi T, Suzuki A, Hayashi S, Tohyama K, Hayashi A, Yamaguchi Y, Takeuchi K, Baba H (2007) Nodal protrusions, increased Schmidt-Lanterman incisures, and paranodal disorganization are characteristic features of sulfatide-deficient peripheral nerves. Glia 55:584-594
84. Hayashi A, Kaneko N, Tomihira C, Baba H (2013) Sulfatide decrease in myelin influences formation of the paranodal axoglial junction and conduction velocity in the sciatic nerve. Glia 61:466-474
85. Marcus J, Dupree JL, Popko B (2000) Effects of galactolipid elimination on oligodendrocyte development and myelination. Glia 30:319-328
86. Hirahara Y, Bansal R, Honke K, Ikenaka K, Wada Y (2004) Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice. Glia 45:269-277
87. Shroff SM, Pomicter AD, Chow WN, Fox MA, Colello RJ, Henderson SC, Dupree JL (2009) Adult CST-null mice maintain an increased number of oligodendrocytes. J Neurosci Res 87:3403-3414
88. Kajigaya H, Tanaka KF, Hayashi A, Suzuki A, Ishibashi T, Ikenaka K, Baba H (2011) Increased numbers of oligodendrocyte lineage cells in the optic nerves of cerebroside sulfotransferase knockout mice. Proc Jpn Acad Ser B Phys Biol Sci 87:415-424
89. Gielen E, Baron W, Vandeven M, Steels P, Hoekstra D, Ameloot M (2006) Rafts in oligodendrocytes: evidence and structurefunction relationship. Glia 54:499-512
90. Sonnino S, Prinetti A (2008) Membrane lipid domains and membrane lipid domain preparations: are they the same thing? Trends Glycosci Glycotechnol 20:315-340
91. Kramer EM, Koch T, Niehaus A, Trotter J (1997) Oligodendrocytes direct glycosyl phosphatidylinositol-anchored proteins to the myelin sheath in glycosphingolipid-rich complexes. J Biol Chem 272:8937-8945
92. Kramer EM, Klein C, Koch T, Boytinck M, Trotter J (1999) Compartmentation of Fyn kinase with glycosylphosphatidylinositol- anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J Biol Chem 274:29042-29049
93. Kim T, Pfeiffer SE (1999) Myelin glycosphingolipid/cholesterol- enriched microdomains selectively sequester the noncompact myelin proteins CNP and MOG. J Neurocytol 28:281-293
94. Simons M, Kramer EM, Thiele C, Stoffel W, Trotter J (2000) Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J Cell Biol 151:143-154
95. Taylor CM, Coetzee T, Pfeiffer SE (2002) Detergent-insoluble glycosphingolipid/cholesterol microdomains of the myelin membrane. J Neurochem 81:993-1004
96. Marta CB, Taylor CM, Coetzee T, Kim T, Winkler S, Bansal R, Pfeiffer SE (2003) Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J Neurosci 23:5461-5471
97. Arvanitis DN, Min W, Gong Y, Heng YM, Boggs JM (2005) Two types of detergent-insoluble, glycosphingolipid/cholesterol- rich membrane domains from isolated myelin. J Neurochem 94:1696-1710
98. Pomicter AD, Deloyht JM, Hackett AR, Purdie N, Sato-Bigbee C, Henderson SC, Dupree JL (2013) Nfasc155H and MAG are specifically susceptible to detergent extraction in the absence of the myelin sphingolipid sulfatide. Neurochem Res 38:2490-2502
99. Ozgen H, Schrimpf W, Hendrix J, de Jonge JC, Lamb DC, Hoekstra D, Kahya N, Baron W (2014) The lateral membrane organization and dynamics of myelin proteins PLP and MBP are dictated by distinct galactolipids and the extracellular matrix. PLoS One 9:e101834
100. Moyano AL, Li G, Lopez-Rosas A, Mansson JE, van Breemen RB, Givogri MI (2014) Distribution of C16:0, C18:0, C24:1, and C24:0 sulfatides in central nervous system lipid rafts by quantitative ultra-high-pressure liquid chromatography tandem mass spectrometry. Anal Biochem 467:31-39
101. DeBruin LS, Haines JD, Bienzle D, Harauz G (2006) Partitioning of myelin basic protein into membrane microdomains in a spontaneously demyelinating mouse model for multiple sclerosis. Biochem Cell Biol 84:993-1005
102. Debruin LS, Harauz G (2007) White matter rafting-membrane microdomains in myelin. Neurochem Res 32:213-228
103. DeBruin LS, Haines JD, Wellhauser LA, Radeva G, Schonmann V, Bienzle D, Harauz G (2005) Developmental partitioning of myelin basic protein into membrane microdomains. J Neurosci Res 80:211-225
104. Mehta NR, Lopez PH, Vyas AA, Schnaar RL (2007) Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. J Biol Chem 282:27875-27886
105. Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL (2005) Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in theCNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol 195:208-217
106. Schnaar RL, Lopez PH (2009) Myelin-associated glycoprotein and its axonal receptors. J Neurosci Res 87:3267-3276
107. Vyas AA, Patel HV, Fromholt SE, Heffer-Lauc M, Vyas KA, Dang J, Schachner M, Schnaar RL (2002) Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci USA 99:8412-8417
108. Schafer DP, Bansal R, Hedstrom KL, Pfeiffer SE, Rasband MN (2004) Does paranode formation and maintenance require partitioning of neurofascin 155 into lipid rafts? J Neurosci 24:3176-3185
109. Baron W, Bijlard M, Nomden A, de Jonge JC, Teunissen CE, Hoekstra D (2014) Sulfatide-mediated control of extracellular matrix-dependent oligodendrocyte maturation. Glia 62:927-942
110. Brown MC, Besio Moreno M, Bongarzone ER, Cohen PD, Soto EF, Pasquini JM (1993) Vesicular transport of myelin proteolipid and cerebroside sulfates to the myelin membrane. J Neurosci Res 35:402-408
111. Baron W, Ozgen H, Klunder B, de Jonge JC, Nomden A, Plat A, Trifilieff E, de Vries H, Hoekstra D (2015) The major myelinresident protein PLP is transported to myelin membranes via a transcytotic mechanism: involvement of sulfatide. Mol Cell Biol 35(1):288-302
112. Rodriguez M, Warrington AE, Pease LR (2009) Invited article: human natural autoantibodies in the treatment of neurologic disease. Neurology 72:1269-1276
113. Warrington AE, Bieber AJ, Ciric B, Pease LR, Van Keulen V, Rodriguez M (2007) A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res 85:967-976